The decreased activity of HSD11B1 in the liver among individuals with obesity has been suggested to be caused by chronic hyperinsulinemia, whereas the sustained hepatic HSD11B1 activity among patients with type 2 diabetes may be caused by insulin resistance and a relative insulin deficiency (6, 11, 12). Here, HSD11B1 is linked to type 2 diabetes mellitus.